Researchers have discovered that at least 400 varieties of medicinal plants have the ability to control Type 2 diabetes. Analysis of existing data from the PubMed database showcases herbal formulations such as BGR-34, commercially available from AIMIL Pharmaceuticals, as a potential solution to this chronic condition.
BGR-34 was prepared by the Council of Scientific and Industrial Research (CSIR) and consists of four medicinal herbs including ‘daruharidra’, ‘gudmar’, ‘methi’ and ‘vijayasar’. Furthermore, additional components ‘giloe’ and ‘majeeth’ were used to enhance immunological properties.
In fact, AIMIL Pharmaceuticals’ Executive Director, Sanchit Sharma – in conjunction with an All India Institute of Medical Sciences study conducted in Kalyani, West Bengal – are attesting to the effectiveness of BGR-34 in not only reducing sugar content in the blood, but also aiding in the management of obesity.
Additionally, other plants such as pomegranate, ‘shilajit’, bean, tea, ‘ginkgo biloba’ and saffron have been studied across India and exhibit properties that reduce high sugar levels in the blood.
Allopathic medicine – as proven from the Galega officinalis plant – can also be derived from herbal sources whereas the sodium-glucose cotransporter-2 (SGLT2) is obtained through the bark of an apple tree.
This promising evidence furthers the tie between nature and herbal remedies and how understanding these relationships can play a pivotal role in future treatments of not only diabetes, but other conditions too.
